Journal of Hematology & Oncology

BMC

Journal websitePeer review: Peer review
Evaluation status available after sign-in

About the journal

Journal of Hematology & Oncology is an open-access journal published by BMC in United Kingdom, publishing in english. It is listed in DOAJ and MEDLINE and PUBMED according to the sources read. Declared publication charge: 4,490 EUR. Declared review time at DOAJ: 6 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
BMC
ISSN
1756-8722
Country
United Kingdom
Languages
english
Access
Open access
Declared publication charge
4,490 EUR
Articles in DOAJ
1858
Declared review time
6 weeks
Declared peer-review model
peer_review

Index listings

  • DOAJ · 2008-06-02
  • MEDLINE · 2008-01-01
  • PUBMED · 2008-05-28
Indexing
DOAJ · MEDLINE · PUBMED
APC
4,490 EUR
Declared review time (DOAJ)
6 weeks — journal-declared only (not measured)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Articles in DOAJ

1858

Most recent article

last month

Average review time (journal-declared via DOAJ)

6weeks

Works in OpenAlex

2186

Last recorded publication year

2026

Reported by OpenAlex in 2 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

229

i10-index

1873

From OpenAlex open data (CC0).

Editorial & policy13
Last DOAJ review date
2026-03-17
Added to DOAJ
2008-06-02
Declared plagiarism screening
Declared
Other fees beyond APC
No
Declared digital preservation
CLOCKSSLOCKSSPMCPortico
Observed digital preservation (Keepers registry)— snapshot 2026-09-21
CLOCKSSPortico
Editorial board
Official page ↗
Norwegian register (HK-dir)— 2026
Level 1 — approved scholarly channel
Open references deposited at Crossref
94%
ORCID iDs in current deposits
8%
Enrolled in Crossref Similarity Check
✓
Deposits licence metadata at Crossref
✓
APC waiver policy
View policy
Peer-review policy
View policy
Identity & continuity4
Alternate titles
Journal of hematology and oncology
Source type
journal
NLM unique ID (PubMed)
101468937
Classification4

Subjects (DOAJ)

Medicine: Internal medicine: Specialties of internal medicine: Diseases of the blood and blood-forming organsMedicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens

LCC codes

RC633-647.5RC254-282

Subject areas

  • CAR-T cell therapy research
  • CAR-T cell therapy research
  • Acute Myeloid Leukemia Research
  • Acute Myeloid Leukemia Research
  • Lymphoma Diagnosis and Treatment
  • Lymphoma Diagnosis and Treatment
  • Cancer Immunotherapy and Biomarkers
  • Cancer Immunotherapy and Biomarkers
Show all subjects (50)
  • Immune Cell Function and Interaction
  • Immune Cell Function and Interaction
  • Multiple Myeloma Research and Treatments
  • Multiple Myeloma Research and Treatments
  • Acute Lymphoblastic Leukemia research
  • Acute Lymphoblastic Leukemia research
  • Immunotherapy and Immune Responses
  • Immunotherapy and Immune Responses
  • Chronic Myeloid Leukemia Treatments
  • Chronic Myeloid Leukemia Treatments
  • Cancer-related molecular mechanisms research
  • Cancer-related molecular mechanisms research
  • Hematopoietic Stem Cell Transplantation
  • Hematopoietic Stem Cell Transplantation
  • Chronic Lymphocytic Leukemia Research
  • Chronic Lymphocytic Leukemia Research
  • Immune cells in cancer
  • Immune cells in cancer
  • MicroRNA in disease regulation
  • MicroRNA in disease regulation
  • RNA modifications and cancer
  • RNA modifications and cancer
  • Protein Degradation and Inhibitors
  • Protein Degradation and Inhibitors
  • Cancer Genomics and Diagnostics
  • Cancer Genomics and Diagnostics
  • Cancer Cells and Metastasis
  • Cancer Cells and Metastasis
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Lung Cancer Treatments and Mutations
  • Lung Cancer Treatments and Mutations
  • Epigenetics and DNA Methylation
  • Epigenetics and DNA Methylation
  • Monoclonal and Polyclonal Antibodies Research
  • Monoclonal and Polyclonal Antibodies Research
  • Cancer, Hypoxia, and Metabolism
  • Cancer, Hypoxia, and Metabolism
  • Virus-based gene therapy research
  • Circular RNAs in diseases
  • Virus-based gene therapy research
  • Circular RNAs in diseases

Keywords (DOAJ)

  • haematology
  • oncology

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: